IonQ, valued at approximately $19.6 billion, stands as the foremost pure-play investment option in quantum computing available to investors. However, the company appears to be struggling despite its market standing. Recent developments indicate that the U.S. government has opted to invest significantly in its quantum computing competitors, leaving IonQ out of the equation.
In a report from The Wall Street Journal, it was revealed that the Trump Administration plans to distribute $2 billion in grants among nine quantum computing companies, acquiring equity stakes in each to ensure a return on investment. While this move has resulted in a significant market surge for several competitors, IonQ has been notably excluded from this financial boon.
Through mid-morning trading, IonQ’s stock saw an increase of 9.5%. The boost, however, is seemingly counterintuitive, as several smaller competitors—including D-Wave Quantum, Infleqtion, and Rigetti Computing—are set to receive substantial grants, each getting $100 million. Furthermore, tech giant IBM is slated to receive an impressive $1 billion, accounting for half of the total funds allocated.
Other firms like Globalfoundries will benefit to the tune of $375 million, while a portion of the funds will also be distributed among privately owned companies, including one linked to Donald Trump Jr.’s 1789 Capital. The stark contrast between the financial opportunities extended to these firms and IonQ—who will receive nothing—has left many questioning the rationale behind the current surge in IonQ’s stock price.
Market analysts caution that despite today’s gains, the outlook for IonQ remains uncertain, with expectations that it may continue to operate at a loss for the foreseeable future. With government backing favoring its competitors, many investors are left pondering whether it might be prudent to reconsider their positions in IonQ amidst these ongoing developments.
Key stock data underscores the current state of IonQ, with a market cap of $20 billion and a day’s trading range fluctuating between $53.97 to $61.12. Despite the uptick in stock price, concerns about long-term profitability and market viability linger among analysts and investors alike.
